Harbour Investments, Inc. Amphastar Pharmaceuticals, Inc. Transaction History
Harbour Investments, Inc.
- $2.82 Billion
- Q2 2024
A detailed history of Harbour Investments, Inc. transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Harbour Investments, Inc. holds 270 shares of AMPH stock, worth $13,524. This represents 0.0% of its overall portfolio holdings.
Number of Shares
270
Previous 270
-0.0%
Holding current value
$13,524
Previous $11,000
9.09%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding AMPH
# of Institutions
279Shares Held
34.2MCall Options Held
25.5KPut Options Held
24.8K-
Black Rock Inc. New York, NY5.94MShares$298 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.67MShares$134 Million0.0% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA1.94MShares$97.4 Million0.19% of portfolio
-
Td Asset Management Inc1.69MShares$84.7 Million0.07% of portfolio
-
Neuberger Berman Group LLC New York, NY1.62MShares$81.3 Million0.05% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $2.46B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...